Barry Eibschutz MD in San Luis Obispo, California

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1987
The Primary Medical Specialty for Barry Eibschutz MD is listed as: Rheumatology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 37
PAC (PECOS ID)#: 0941233167
NPI #: 1164464566
NPI Created On: 06/11/2006
NPI Last Updated Listed as: 09/23/2016
Primary Taxonomy Code: 207RR0500X
License Number:
G78005
Listed Gender: Male

Services and Procedures include:

1. Aspiration and/or injection of large joint or joint capsule
2. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
3. Infusion into a vein for therapy, prevention, or diagnosis
4. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
5. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
6. Infusion of chemotherapy into a vein up to 1 hour
7. Infusion of chemotherapy into a vein
8. New patient office or other outpatient visit, typically 20 minutes
9. New patient office or other outpatient visit, typically 30 minutes
10. New patient office or other outpatient visit, typically 45 minutes
11. Established patient office or other outpatient visit, typically 10 minutes
12. Established patient office or other outpatient visit, typically 15 minutes
13. Established patient office or other outpatient, visit typically 25 minutes
14. Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes
15. Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
16. Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
17. Injection, denosumab, 1 mg
18. Injection, methylprednisolone acetate, 80 mg
19. Injection, diphenhydramine hcl, up to 50 mg
20. Injection, golimumab, 1 mg, for intravenous use